Data on the association of MHT/HC with BC risk in women with BRCA mutations are included in Additional file 1: Figures S1A, B. Most studies indicated no association with BC, a few indicated an increased risk for MHT/HC use in women with BRCA1, and a little less than one-third indicated a decreased risk of BC. Here, BRCA1 is linked to breast cancer.